key: cord-0758210-a4qg3wkf
authors: Di Vincenzo, Angelo; Busetto, Luca; Vettor, Roberto; Rossato, Marco
title: Prostate specific antigen in COVID‐19 patients
date: 2021-03-04
journal: Andrology
DOI: 10.1111/andr.12987
sha: 2d48f2cac81b4055b11256af0726f74023c8102d
doc_id: 758210
cord_uid: a4qg3wkf

We read with interest the paper by Ruan et al. reporting that in patients with COVID-19 there is no direct urogenital involvement, being SARS-CoV-2 RNA undetectable in the urogenital secretions.1.

Dear Editor,

We read with interest the paper by Ruan et al. reporting that in patients with COVID-19 there is no direct urogenital involvement, being SARS-CoV-2 RNA undetectable in the urogenital secretions. 1 It is well known that subjects with SARS-CoV-2 infection may be asymptomatic or experience mild symptoms although patients may develop acute respiratory distress syndrome because of a SARS-CoV-2 related interstitial pneumonia requiring non-invasive and invasive ventilation, intensive care unit (ICU) and leading also to death above all in aged subjects with multiple comorbidities. 

No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Cell entry mechanisms of SARS-CoV-2

Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells